Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Type Therapeutic or Technology Institution Stage Project Objective Details
Parkinson's Disease iPS Cell Small molecule therapy Zenobia Therapeutics
Proof of Concept, Research Insights
Bone or Cartilage Disease Adult Stem Cell Donor cell therapy UCLA
Proof of Concept
Age-related macular degeneration iPS Cell Exploring disease mechanisms UCSD
Research Insights
Hemophilia A Adult Stem Cell Gene modification COH
Development Candidate, Proof of Concept
Epilepsy Embryonic Stem Cell Donor cell therapy Neurona Therapeutics
Development Candidate
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy UCSD
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy ViaCyte
Development Candidate
Skeletal/Smooth Muscle disorders Adult Stem Cell Small molecule therapy Stanford
Development Candidate
Spinal Cord Injury Embryonic Stem Cell Donor cell therapy UCSD
Development Candidate
Liver Disease Embryonic Stem Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Muscular Dystrophy Embryonic Stem Cell,
iPS Cell
Personalized cell therapy UCLA
Development Candidate
Stroke iPS Cell Donor cell therapy UCLA
Development Candidate
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Antibody UCSD
Development Candidate, Proof of Concept
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Donor cell therapy UCSF
Development Candidate
Spinal Cord Injury Adult Stem Cell Donor cell therapy UC Irvine
Development Candidate
Intestinal Disease,
Neurological Disorders
Adult Stem Cell Specific Cell Type Derivation Stanford
Tool/Resources/Bottleneck
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Solid Tumors iPS Cell Gene-modified, donor cell therapy Fate Therapeutics
IND
Sickle Cell Disease Adult Stem Cell Donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
B cell cancers,
Leukemia
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Clinical Trial, Phase 1 or Phase 1/2
Beta Thalassemia Adult Stem Cell Gene-modified, personalized cell therapy Sangamo
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy Orchard Therapeutics
Clinical Trial, Phase 2
Lung Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Bone or Cartilage Disease Adult Stem Cell Small molecule therapy MAX BioPharma
Pre-IND/IDE or Equivalent
Bladder or Urinary Tract Disorder,
Incontinence
iPS Cell Personalized cell therapy Stanford
Pre-IND/IDE or Equivalent
Retinitis Pigmentosa Embryonic Stem Cell Donor cell therapy UC Irvine
Pre-IND/IDE or Equivalent
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test CHORI
Regulated Lab Test, Ready for Validation
Parkinson's Disease Adult Stem Cell Gene-modified, donor cell therapy UCSF
IND
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
IND
Prostate Cancer Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics
IND
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Ovarian Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Development Candidate, Proof of Concept
Thymic Disorder, 22q11 Deletion/DiGeorge Embryonic Stem Cell,
iPS Cell
Donor cell therapy Stanford
Development Candidate, Proof of Concept
Heart Disease,
Danon Disease
Adult Stem Cell Gene-modified, personalized cell therapy UCSD
Development Candidate, Proof of Concept
Cancer Adult Stem Cell Gene-modified, donor cell therapy UCLA
Development Candidate, Proof of Concept
Dementia iPS Cell Donor cell therapy Gladstone
Development Candidate, Proof of Concept
Type 1 diabetes Embryonic Stem Cell Gene-modified, donor cell therapy Salk
Development Candidate, Proof of Concept
Vision Loss iPS Cell Small molecule therapy UCSD
Development Candidate, Proof of Concept
Liver Disease iPS Cell Gene-modified, donor cell therapy CHLA
Development Candidate, Proof of Concept
Autism iPS Cell Small molecule therapy Scripps
Development Candidate, Proof of Concept
Bladder or Urinary Tract Disorder,
Solid Tumors
Embryonic Stem Cell Donor cell therapy Stanford
Development Candidate, Proof of Concept
Hearing Loss iPS Cell Model system development USC
Proof of Concept, Tool/Resources/Bottleneck
Hearing Loss Adult Stem Cell Protein/peptide therapy Stanford
Development Candidate, Proof of Concept
HIV/AIDS Personalized cell therapy COH
IND
Leukemia, Acute Myeloid (AML) Cancer Stem Cell Gene-modified, personalized cell therapy UCSF
Pre-IND/IDE or Equivalent
Age-related macular degeneration iPS Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
Spina Bifida Adult Stem Cell Donor cell therapy UC Davis
IND

Pages

Icon for csv export